360 related articles for article (PubMed ID: 25528252)
1. Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barré syndrome: a case report.
Hughes CL; Yorio JT; Kovitz C; Oki Y
J Med Case Rep; 2014 Dec; 8():455. PubMed ID: 25528252
[TBL] [Abstract][Full Text] [Related]
2. Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
Arakelyan N; Berthou C; Desablens B; de Guibert S; Delwail V; Moles MP; Quittet P; Jais JP; Colonna P; Andrieu JM;
Cancer; 2008 Dec; 113(12):3323-30. PubMed ID: 18988286
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
[TBL] [Abstract][Full Text] [Related]
4. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
Viviani S; Zinzani PL; Rambaldi A; Brusamolino E; Levis A; Bonfante V; Vitolo U; Pulsoni A; Liberati AM; Specchia G; Valagussa P; Rossi A; Zaja F; Pogliani EM; Pregno P; Gotti M; Gallamini A; Rota Scalabrini D; Bonadonna G; Gianni AM; ; ;
N Engl J Med; 2011 Jul; 365(3):203-12. PubMed ID: 21774708
[TBL] [Abstract][Full Text] [Related]
5. A successful initiation of treatment of Hodgkin's lymphoma with adriamycin-bleomycin-vinblastine-dacarbazine dose reduction in a patient with fulminant hepatic failure and co-infection with human immunodeficiency virus and hepatitis B.
Veeraballi S; Chan KH; Slim J; Shaaban HS; Guron G
J Oncol Pharm Pract; 2022 Mar; 28(2):479-485. PubMed ID: 34590528
[TBL] [Abstract][Full Text] [Related]
6. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Behringer K; Goergen H; Hitz F; Zijlstra JM; Greil R; Markova J; Sasse S; Fuchs M; Topp MS; Soekler M; Mathas S; Meissner J; Wilhelm M; Koch P; Lindemann HW; Schalk E; Semrau R; Kriz J; Vieler T; Bentz M; Lange E; Mahlberg R; Hassler A; Vogelhuber M; Hahn D; Mezger J; Krause SW; Skoetz N; Böll B; von Tresckow B; Diehl V; Hallek M; Borchmann P; Stein H; Eich H; Engert A; ; ;
Lancet; 2015 Apr; 385(9976):1418-27. PubMed ID: 25539730
[TBL] [Abstract][Full Text] [Related]
7. [Acute sensory neuropathy associated with Hodgkin's lymphoma: a case study].
Yokota Y; Mitsuke K; Minami H; Morita A; Takahashi H; Kamei S
Rinsho Shinkeigaku; 2019 Jun; 59(6):349-355. PubMed ID: 31142709
[TBL] [Abstract][Full Text] [Related]
8. A Case of Paraneoplastic Cerebellar Degeneration that Preceded the Diagnosis of Classical Hodgkin's Lymphoma by 16 Months.
Arratibel N; Sobejano E; Moran JC; Diaz LG; Blázquez A; Baile M; Veiga Á; Caballero MD; García-Sanz R
Am J Case Rep; 2020 Jun; 21():e922342. PubMed ID: 32574156
[TBL] [Abstract][Full Text] [Related]
9. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
[TBL] [Abstract][Full Text] [Related]
10. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
11. A sinister itch: prurigo nodularis in Hodgkin lymphoma.
Seshadri P; Rajan SJ; George IA; George R
J Assoc Physicians India; 2009 Oct; 57():715-6. PubMed ID: 20329432
[TBL] [Abstract][Full Text] [Related]
12. [Guillain-Barré syndrome in patients treated for Hodgkin disease].
Apjok E; Marosi A; Magyarosy E
Orv Hetil; 2003 May; 144(21):1039-40. PubMed ID: 12847857
[TBL] [Abstract][Full Text] [Related]
13. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Al-Ali HK; Wittekind C; Niederwieser D
Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin's lymphoma--the great teacher.
Connors JM
N Engl J Med; 2011 Jul; 365(3):264-5. PubMed ID: 21774715
[No Abstract] [Full Text] [Related]
15. Classical Hodgkin's lymphoma: past, present and future perspectives.
Eyre TA; King AJ; Collins GP
Br J Hosp Med (Lond); 2013 Nov; 74(11):612-8. PubMed ID: 24220522
[No Abstract] [Full Text] [Related]
16. Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial.
Arakelyan N; Jais JP; Delwail V; Brière J; Moles-Moreau MP; Sénécal D; Berthou C; Desablens B; Colonna P; Andrieu JM;
Cancer; 2010 Sep; 116(17):4054-62. PubMed ID: 20564152
[TBL] [Abstract][Full Text] [Related]
17. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
Engert A; Franklin J; Eich HT; Brillant C; Sehlen S; Cartoni C; Herrmann R; Pfreundschuh M; Sieber M; Tesch H; Franke A; Koch P; de Wit M; Paulus U; Hasenclever D; Loeffler M; Müller RP; Müller-Hermelink HK; Dühmke E; Diehl V
J Clin Oncol; 2007 Aug; 25(23):3495-502. PubMed ID: 17606976
[TBL] [Abstract][Full Text] [Related]
18. Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin's disease.
Kömürcü S; Ozet A; Altundag MK; Arpaci F; Oztürk B; Celasun B; Tezcan Y
Ann Hematol; 2002 Jan; 81(1):57-8. PubMed ID: 11807639
[No Abstract] [Full Text] [Related]
19. Treatment for relapse in stage I/II Hodgkin's lymphoma after initial single-modality treatment.
Rueda A; Olmos D; Viciana R; Alba E
Clin Lymphoma Myeloma; 2006 Mar; 6(5):389-92. PubMed ID: 16640815
[TBL] [Abstract][Full Text] [Related]
20. [Particularities of Hodgkin's lymphoma].
Mounier N; Fermé C
Rev Prat; 2010 Jan; 60(1):75-9. PubMed ID: 20222316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]